21 January 2019

Rinske van Oorschot from the Van der Reijden group (Laboratory Hematology, Dept Laboratory Medicine), theme Cancer development and immune defense, has published two papers on the transcription factor GFI1B in Haematologica.

Earlier work from the Van der Reijden group showed that an inherited GFI1B mutation severely disturbed the formation of megakaryocytes and their production of blood platelets. Together with the Dept of Molecular Biology, Radboud University and Sanquin Blood Supply, Amsterdam, Rinske now shows that mutant GFI1B functions in a dominant-negative manner by squelching the chromatin modifying CoREST complex, making it unavailable for wild type GFI1B1. Proteomics on megakaryocytes generated from patient-derived induced pluripotent stem cells identified a plethora of pathways regulated by GFI1B.

In another study, Rinske shows together with groups from Leuven, Belgium and Cambridge, U.K., the functional effects of new inherited GFI1B variants observed in cases with unexplained bleedings2. This work identifies novel important functional domains in GFI1B. Together, Rinske's studies shed important light on the function of GFI1B in the formation of platelets and bleeding disorders.
  1. Molecular mechanisms of bleeding disorder-associated GFI1BQ287* mutation and its affected pathways in megakaryocytes and platelets: Van Oorschot R et al, Haematologica, January 2019
  2. Inherited missense variants that affect GFI1B function do not necessarily cause bleeding diatheses: Van Oorschot R et al, Haematologica, December 2018
  • Want to know more about these subjects? Click on the buttons below for more news.

    Laboratory Medicine

Related news items

T cell immunity is directed by tetraspanin CD53

5 July 2022 T cells are immune cells that are key for the defense against pathogens and cancer. T cells depend on the membrane protein CD45 to initiate T cell receptor signaling, but how CD45 is controlled at the molecular level is poorly understood. read more

A single protein complex balances the very first lineage decision of cells in human: towards foetus or placenta

21 June 2022 The international group of researchers spearheaded by Dick Zijlmans and Hendrik Marks together with colleagues from KU Leuven, examined which proteins are associated with the chromatin and how this affects gene transcription. read more

Dutch Society of Clinical Chemistry Science & Innovation Award for the team of Hans Jacobs

14 June 2022 The team of Hans Jacobs pioneers on the development of personalized diagnostics to measure minimal residual disease in patients with multiple myeloma. read more

2.5 million Euros for cancer research into ovarian cancer and immunotherapy

15 April 2021 The Radboudumc receives 2.5 million Euros from the Dutch Cancer Society (KWF) for three studies to ensure oncological progress during COVID-19 period. read more

RIMLS PhD grants awarded to eight RIMLS (j)PI's

12 September 2019 Recently, RIMLS held an internal call for Radboudumc junior researcher (PhD) positions. Congratulations for all the awardees and all the best in conducting the research projects. read more

Natural Killer cell therapy Hematology teams up with MWH4impact

25 July 2018 The Departments of Laboratory Medicine and Hematology entered into a partnership with the Social impact foundation MWH4impact on Natural Killer cell therapy. read more